Abbott India Ltd
NSE:ABBOTINDIA
Abbott India Ltd
Cash from Financing Activities
Abbott India Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Abbott India Ltd
NSE:ABBOTINDIA
|
Cash from Financing Activities
-₹6.4B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Financing Activities
-₹12.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Financing Activities
-₹11.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Financing Activities
-₹54.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Cash from Financing Activities
-₹29.8B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash from Financing Activities
-₹7.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Abbott India Ltd's Cash from Financing Activities?
Cash from Financing Activities
-6.4B
INR
Based on the financial report for Mar 31, 2023, Abbott India Ltd's Cash from Financing Activities amounts to -6.4B INR.
What is Abbott India Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-44%
Over the last year, the Cash from Financing Activities growth was 0%. The average annual Cash from Financing Activities growth rates for Abbott India Ltd have been -43% over the past three years , -44% over the past five years .